Paul De Leyn

University Hospital of Zurich, KU Leuven

Papers

2

Total Citations

21

H-Index

2

About

Paul De Leyn is a leading thoracic surgeon whose research focuses on improving surgical outcomes for esophageal and lung cancers. He is best known for his work on quality indicators in esophageal cancer surgery, notably his 2009 paper “Quality Indicators of Surgery for Adenocarcinoma of the Esophagus and Gastroesophageal Junction,” which has garnered 11 citations and established benchmarks for surgical excellence. More recently, De Leyn has advanced minimally invasive thoracic surgery through his systematic review on the use of intravenous indocyanine green (ICG) in segmental lung resections (2024, 10 citations). This work evaluates ICG’s efficacy in identifying intersegmental planes during video- and robot-assisted thoracoscopic segmentectomies, a critical step for precise, lung-sparing surgery. By synthesizing evidence on this innovative technique, De Leyn has helped refine intraoperative visualization, reducing complications and improving patient outcomes. His contributions bridge traditional quality metrics with cutting-edge technology, making him a pivotal figure in thoracic oncology. With a career dedicated to evidence-based surgical practice, De Leyn continues to shape standards for esophageal and lung cancer care, impacting both clinical protocols and patient survival.

Research Focus

Key Achievements

2
H-Index
2
Papers
21
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Quality Indicators of Surgery for Adenocarcinoma of the Esophagus and Gastroesophageal Junction
11 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University Hospital of Zurich, KU Leuven

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago